Snapback Rally Sends Axovant Sciences 10% Higher Today
One day after shares collapsed 70% in the wake of a disappointing trial failure in Alzheimer's disease, Axovant Sciences (NASDAQ: AXON) is bouncing back by 10% at 3:45 pm EDT today.
Axovant Sciences' long-shot bet that it could profit from resurrecting the Alzheimer's-disease drug intepirdine has failed to pay out.
IMAGE SOURCE: GETTY IMAGES.
Source: Fool.com
